Rodman & Renshaw Starts Infinity Pharmaceutical (INFI) at Market Perform
Tweet
Share
E-mailGet Alerts INFI Hot Sheet
Price: $0.04 --0%
Rating Summary:
12 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 18 | New: 20
Rating Summary:
12 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 18 | New: 20
Join SI Premium – FREE
Rodman & Renshaw initiates coverage on Infinity Pharmaceutical (NASDAQ: INFI) with a Market Perform.
For an analyst ratings summary and ratings history on Infinity Pharmaceutical click here. For more ratings news on Infinity Pharmaceutical click here.
Shares of Infinity Pharmaceutical closed at $8.31 yesterday.
For an analyst ratings summary and ratings history on Infinity Pharmaceutical click here. For more ratings news on Infinity Pharmaceutical click here.
Shares of Infinity Pharmaceutical closed at $8.31 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Starts Luxshare Precision (2475:HK) at Buy
- Craig-Hallum Starts Horizon Quantum (HQ) at Buy
- Goldman Sachs Resumes Luxshare Precision (002475:CH) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Rodman & RenshawSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
